Tufts CSDD Patient Engagement Survey

Agency will be reorganizing field force and compliance functions.

EU proposal focuses on a subset of underserved rare diseases—exploring the gaps in those conditions for which there is no approved treatment option.

Companies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.

Panel at recent Talk Health event at Le Méridien, in Philadelphia, PA, on September 11th, 2023, focused on what success looks like in audio from a publisher, vendor, and HCP perspectives.

With lessons from COVID now established, concrete ideas on improving drug development strategy for future health threats are beginning to take shape.

If a future Supreme Court ruling on diversity were to be applicable to clinical research, the FDA’s positions on diversity will take on even more importance.